Patrick H. Nachman, MD, FASN

ASN Biography

Patrick H. Nachman, MD, FASN, is a Professor of Medicine at the University of Minnesota. His research efforts on the study of glomerulonephritis and small-vessel vasculitis. This research has spanned the spectrum from bench to bedside, more recently focusing on translational studies in vasculitis and glomerulonephritis and epidemiologic and clinical studies in both fields of nephrology. Of particular interest are predictors of disease relapse, individualized immunotherapy, and the prevention of long term complications of treatment.

Dr. Nachman has been a senior investigator, mentored and participated in several cohort studies on outcome analysis in patients with Antineutrophil Cytoplasmic Autoantibody (ANCA)-associated vasculitis, membranous nephropathy, and focal segmental glomerulosclerosis (FSGS). He mentors young investigators at various stages of training in glomerular diseases and small vessel vasculitis.

Additionally, Dr. Nachman's educational efforts include multiple contributions to the Nephrology Self-Assessment Program (NephSAP) (2008, 2010, 2012, and 2014), and the Kidney Disease Improving Global Outcomes (KDIGO) guidelines for glomerular diseases (2012), as well as co-chairing the glomerular disease in-depth course at the American Society of Nephrology (2008-2014) and serving as Chair to the ASN Post Graduate Education Committee (2013-2019).

Current Position/Titles

Professor of Medicine, University of Minnesota; Director, Division of Nephrology and Hypertension, University of Minnesota; Director, Minnesota Multidisciplinary Vasculitis Program, University of Minnesota; Medical Director, Nephrology Service Line, M Health Fairview.

Degrees/Training

  • B.S., American University of Beirut, 1983
  • M.D., Boston University School of Medicine, Boston, MA, 1989
  • Internal Medicine Residency: University of North Carolina, Chapel Hill, NC 1992
  • Nephrology Fellowship: University of North Carolina, Chapel Hill, NC 1996
  • Research/Post-Doc Training: University of North Carolina, Chapel Hill, NC 1995

ASN Service

  • Member, Post Graduate Education Committee, 2007-2013
  • Chair, Post Graduate Education Committee, 2013-2018
  • Past-Chair, Post Graduate Education Committee 2019
  • Member, Education Committee 2013-2018
  • Co-chair, Glomerular Disease Early Program, ASN Kidney Week (2009 - 2014)
  • Member, Glomerular Disease Advisory Committee, 2008-2014
  • Nephrology Self-Assessment Program. 2008 - 2014
  • ASN Kidney Cure Grant Review Committee, 2020-present
  • ASN Renal Weekends/Highlights, 2011 2013 and 2019-present
  • ASN Board Review Course, 2012-present

Leadership Positions

  • Member, Kidney Health Initiative, (2012 - present)
  • Member, Kidney Health Initiative Board of Director, (2020 - present)
  • Food and Drug Administration, Cardiovascular and Renal Drug Advisory Board (2016 - present)
  • Deputy Director, University of North Carolina Kidney Center (2015 - 2018)
  • Member, General Clinical Research Center Scientific Advisory Committee, UNC (1997-2012)
  • Member, Office of Human Research Ethics: Biomedical Institutional Review Board, UNC (2002-2009)

Honors

  • Marion Stedman Covington Distinguished Professor (UNC)
  • UNC Division of Nephrology and Hypertension Maestro Award 2018
  • UNC Health Care and Faculty Physicians Award - Carolina Care Excellence 2015
  • UNC Internal Medicine Housestaff Faculty Award 2007
  • Boston University School of Medicine, Dr. Samuel Poplack Student Award 1989
  • B.S. with Distinction, American University of Beirut 1983

Board Certification

  • American Board of Internal Medicine (1992), Nephrology (1996, 2006, 2016).

Research Interests

My research interests have spanned the gamut from bench to bedside, starting with the study of the immune dysregulation leading to Antineutrophil Cytoplasmic Autoantibodies formation. Over the years, my research shifted from the bench to the clinical and translational aspects of research in ANCA vasculitis as well as glomerular diseases. My work has focused on the clinical course, outcomes, and complications of vasculitis, FSGS and membranous nephropathy. I have contributed to epidemiological studies, clinical trials, public/private partnerships in vasculitis, lupus nephritis, and several glomerular diseases and developed a personalized risk-benefit decision analysis tool for prophylactic anticoagulation in membranous nephropathy.

Personal Statement

I am committed to three primary goals: developing new therapies for patients with kidney disease, collaborating across disciplines and institutions, and post-graduate education. These goals seek to bridge the gap between research and clinical care while advocating for equity at all levels of nephrology. I believe in improving access to clinical studies for patients with kidney disease while addressing the obstacles, demands and disparities in patient care and participation in clinical research. My commitment to education, scientific discovery and patient advocacy is guided by and aligned to ASN's mission to care for patients with kidney disease.